REDBUD LABS, INC.
- DURHAM, NC 27713-3324
- redbudlabs.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $1.8M
- Awards on record
- 1
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
REDBUD LABS, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About REDBUD LABS, INC.
- Headquarters
- DURHAM, NC 27713-3324
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIKJGXVMFV9U14
- CAGE66CA6
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $1.8M
- Awards on record
- 1
- Top funding agencies
- National Institutes of Health
Awards
75N93023C00029
Completed: Period of performance ended Sep 14, 2025IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.8M
- Period of performance
- Sep 15, 2023 – Sep 14, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N93023C00029 IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE… | Department of Health and Human Services · National Institutes of Health | 541715 · AN41HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $1.8M | Sep 15, 2023 – Sep 14, 2025 | Completed: Period of performance ended Sep 14, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 25 awards
- Total awarded
- $25,418,736
- By phase
- SBIR Phase I: 13
- SBIR Phase II: 10
- STTR Phase I: 1
- STTR Phase II: 1
- By agency
- Department of Health and Human Services: 23
- National Science Foundation: 2
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 3
- 2023: 1
- 2022: 6
- 2021: 1
- 2020: 2
- 2019: 3
- 2018: 2
- 2017: 2
- 2016: 3
- 2015: 1
- 2012: 1
Awards (most recent first)
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $2,550,000
Jul 10, 2024 – Jun 30, 2026
Solicitation PA20-272 (2020) · Topic 400
System for unitary automation of library preparation
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $2,507,350
May 20, 2024 – Mar 31, 2026
Solicitation PA20-272 (2020) · Topic 400
Rapid point-of-care molecular test for HCV VL
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,996,224
Apr 2, 2024 – Mar 31, 2026
Solicitation PA23-230 (2023) · Topic NIAID
IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE STERILIZATION AND PRODUCE AN INSTRUMENT DESIGNED WITH PORTABILITY AND R
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $1,799,353
Solicitation PHS-2023-1 (2023) · Topic 120
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $279,013
Sep 16, 2022 – Sep 15, 2023
Solicitation PA21-259 (2021) · Topic 400
A modular platform for infectious disease surveillance at point-of-need.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,982,637
Sep 5, 2022 – Aug 31, 2024
Solicitation PA19-272 (2019) · Topic NIAID
Point-of-care HIV viral load system using RPA and MXR
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,902,994
Aug 1, 2022 – Jul 31, 2024
Solicitation PA21-259 (2021) · Topic 105
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,986,695
Jun 21, 2022 – May 31, 2024
Solicitation PA21-262 (2021) · Topic 400 · Research partner: UNIV OF NORTH CAROLINA CHAPEL HILL
MEMS-enhanced solid-phase isothermal amplification for rapid, multiplexed molecular diagnostics
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $304,329
Jun 1, 2022 – May 31, 2023
Solicitation PA21-259 (2021) · Topic NIBIB
System for unitary automation of library preparation
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $292,788
Feb 17, 2022 – Feb 16, 2023
Solicitation PA20-260 (2020) · Topic 400
Rapid point-of-care molecular test for HCV VL
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $288,729
Sep 1, 2021 – Aug 31, 2022
Solicitation PA20-260 (2020) · Topic NIAID
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood.
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $296,954
Sep 10, 2020 – Sep 9, 2021
Solicitation PA18-575 (2018) · Topic 400 · Research partner: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
A modular platform for infectious disease surveillance at point-of-need.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $590,917
Aug 7, 2020 – Jul 31, 2022
Solicitation PA19-272 (2019) · Topic NIAID
Point-of-care HIV viral load system using RPA and MXR
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $298,450
Aug 1, 2019 – Jul 31, 2020
Solicitation PA18-574 (2018) · Topic NIAID
System for faster microarray assays and end-to-end workflow automation
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2019 · $1,986,975
Aug 1, 2019 – Jul 31, 2021
Solicitation PA18-574 (2018) · Topic 400
Microplate bioreactor for high throughput biopharmaceutical process development
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $297,446
Apr 1, 2019 – Mar 31, 2021
Solicitation PA18-574 (2018) · Topic 400
Device for rapid, on-chip, sample-to-answer bacterial identification and drug susceptibility testing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $294,357
Aug 1, 2018 – Jul 31, 2019
Solicitation PA16-302 (2016) · Topic NIAID
Device for rapid extraction of rare pathogens from raw samples
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $2,135,785
Jan 10, 2018 – Dec 31, 2020
Solicitation PA16-302 (2016) · Topic R
Microarray performance enhancement using microfluidic mixing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $298,963
Jul 1, 2017 – Jun 30, 2019
Solicitation PA16-302 (2016) · Topic 400
SBIR Phase II: Microfilm to enable enhanced mixing in low-resource diagnostics
SBIR Phase II · National Science Foundation · 2017 · $725,804
Apr 1, 2017 – Mar 31, 2019
Solicitation year 2015 · Topic MI
HLS Rugged point of care device for global hemostasis testing of whole blood
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,481,314
Aug 1, 2016 – May 31, 2019
Solicitation PA14-071 (2014) · Topic NHLBI
Device for rapid extraction of rare pathogens from raw samples
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $297,090
Jul 1, 2016 – Dec 31, 2017
Solicitation PA15-269 (2015) · Topic NIAID
SBIR Phase I: Microfilm to enable enhanced mixing in low-resource diagnostics
SBIR Phase I · National Science Foundation · 2016 · $146,034
Jan 1, 2016 – Jun 30, 2016
Solicitation year 2015 · Topic MI
HLS-Rugged point-of-care device for global hemostasis testing of whole blood
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $197,455
Sep 1, 2015 – Jun 30, 2016
Solicitation PA14-071 (2015) · Topic NHLBI
Triple Analysis of Blood Clotting using Driven and Diffusing Microbeads
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $481,080
Solicitation PA10-122 (2012) · Topic NHLBI · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with REDBUD LABS, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.